Variant report
Variant | nsv508233 |
---|---|
Chromosome Location | chr3:103046350-103057810 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs201918684 | chr3:103055224-103055225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554364398 | chr3:103055237-103055238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73849661 | chr3:103055244-103055245 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs191609236 | chr3:103055270-103055271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140504806 | chr3:103055299-103055300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576327400 | chr3:103055330-103055331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150439402 | chr3:103055389-103055390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138178088 | chr3:103055401-103055402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558989043 | chr3:103055421-103055422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558253346 | chr3:103055437-103055438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577216458 | chr3:103055446-103055447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs79226126 | chr3:103055449-103055450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200109179 | chr3:103055452-103055453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182333480 | chr3:103055472-103055473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs138202662 | chr3:103055482-103055483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559516313 | chr3:103055504-103055505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574506641 | chr3:103055514-103055515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542148565 | chr3:103055523-103055524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541411008 | chr3:103055531-103055532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563614223 | chr3:103055614-103055615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530810712 | chr3:103055665-103055666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9869350 | chr3:103055693-103055694 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs149621172 | chr3:103055705-103055706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187581702 | chr3:103055713-103055714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547531850 | chr3:103055715-103055716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566263553 | chr3:103055724-103055725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553042214 | chr3:103055727-103055728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565824176 | chr3:103055730-103055731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144321385 | chr3:103055737-103055738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139361208 | chr3:103055745-103055746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs193255916 | chr3:103055771-103055772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368762680 | chr3:103055782-103055783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572015042 | chr3:103055806-103055807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561212637 | chr3:103055829-103055830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143269790 | chr3:103055871-103055872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10511210 | chr3:103055872-103055873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185400912 | chr3:103055886-103055887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534724809 | chr3:103055898-103055899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568076813 | chr3:103055938-103055939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552747523 | chr3:103055942-103055943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574574961 | chr3:103055954-103055955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs147535890 | chr3:103055955-103055956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190325264 | chr3:103055981-103055982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140340481 | chr3:103055990-103055991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545743237 | chr3:103055995-103055996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565289102 | chr3:103056008-103056009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192274620 | chr3:103056015-103056016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144186494 | chr3:103056039-103056040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150752751 | chr3:103056044-103056045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531389667 | chr3:103056100-103056101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:103055200-103056000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr3:103056000-103056400 | Enhancers | H9 Cell Line | embryonic stem cell |